Skip to main content
Clinical Trials/CTRI/2016/01/006551
CTRI/2016/01/006551
Completed
Phase 4

Dexmedetomidine infusion for suppression of hyperdynamic responses to microlaryngoscopy - Suppression of hyperdynamic response of MLscopy with Dexmedetomidine

okmanya Tilak Municipal Medical College and General Hospital0 sites60 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: null- ASA II and III
Sponsor
okmanya Tilak Municipal Medical College and General Hospital
Enrollment
60
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
okmanya Tilak Municipal Medical College and General Hospital

Eligibility Criteria

Inclusion Criteria

  • Patients of ASA grade I to III
  • Patients scheduled for elective Microlaryngoscopy procedure under General Anaesthesia
  • Preoperatively tracheostomised patients

Exclusion Criteria

  • Patients on sedatives, hypnotic and antidepressants
  • H/o severe cardiovascular hepatic and renal diseases
  • Baseline Heart rate less than 50 bpm SBP less than 90 mm Hg DBP less than 60 mmHg before
  • premedication, atrioventricular block more than first degree or left bundle\-branch block

Outcomes

Primary Outcomes

Not specified

Similar Trials